E-mail:gzliang@cqu.edu.cn    Tel: (86)2365102507

List of peptide properties
DFBP ID - DFBPANHY0122(Antihypertensive peptide)
DFBP ID DFBPANHY0122
Peptide sequence LLYQEPVLGPVRGPFPIIV
Type Native peptide
Peptide/Function name Antihypertensive peptide
Function-activity relationship
Main bioactivity Antihypertensive activity
Otheir bioactivity ACE-inhibitory activity [D1], Immunomodulatory activity [D2], Multifunctional activity [D3]
Calculated physicochemical properties
Three-letter amino acid Leu-Leu-Tyr-Gln-Glu-Pro-Val-Leu-Gly-Pro-Val-Arg-Gly-Pro-Phe-Pro-Ile-Ile-Val
Single-letter amino acid LLYQEPVLGPVRGPFPIIV
Peptide length 19
Peptide mass
Experimental mass Theoretical mass
N.D 2107.55 Da c
Net charge 0.00 c
Isoelectric point (pI) 6.88 c
IC50 N.D
pIC50 N.D
GRAVY 0.8316 c
Hydrophilic residue ratio 78.95% c
Peptide calculator
To calculate the physicochemical properties of bioactive peptide.
Peptide source & Food-borne protein(s) search
Classification Animal
Organism/Source Milk protein
Precursor protein β-Casein
Residue position f(191-209)
Precursor protein(s) search
Link-research
There are no literature reports on the discovery of this sequence in other food-source proteins.
Biological/Functional activity & target protein
Antihypertensive activity

The hydrolysates containing ACE inhibitor (peptide LLYQEPVLGPVRGPFPIIV) from caseins showed a clear antihypertensive action a spontaneously hypertensive rat at a dosage of 15 mg/kg (-29.8 mm Hg at 4 h), so the peptide was a potential antihypertensive peptide.

Specific target protein(s) N.D
Taste properties & Structure
Bitterness
Literature report N.D
Bitter prediction tools Bitter taste prediction
SMILES N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CCC(=O)N)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(CC(C)C)C(=O)NCC(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)NCC(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])([C@]([H])(CC)C)C(=O)N[C@@]([H])([C@]([H])(CC)C)C(=O)N[C@@]([H])(C(C)C)C(=O)O
Preparation method
Mode of preparation

Enzymatic hydrolysis

Enzyme(s)/starter culture

Hydrolysis with an extracellular proteinase from Lactobacillus helveticus CP790.

Stability & Cytotoxicity
Peptide stability
Literature report: N.D
EHP-Tool: Enzymatic Hydrolysis Prediction Tool (EHP-Tool)
Peptide cytotoxicity
Literature report: Non-Toxin
Prediction: ToxinPred
Additional information
Additional information N.D
Database cross-references
DFBP
[D1] DFBPACEI1154
[D2] DFBPIMMU0090
[D3] DFBPMUFU0227
BIOPEP-UWM [D4] 8174
APD [D5] -
BioPepDB [D6] -
MBPDB [D7] -
Reference(s)
Primary literature Yamamoto, N., Akino, A., Takano, T. Antihypertensive Effect of the Peptides Derived from Casein by an Extracellular Proteinase from Lactobacillus helveticus CP790. Journal of Dairy Science. 1994, 77, 917-22.
Other literature(s)

[1] Ha, G.E., et al., Identification of Antihypertensive Peptides Derived from Low Molecular Weight Casein Hydrolysates Generated during Fermentation by Bifidobacterium longum KACC 91563. Korean Journal for Food Science of Animal Resources, 2015. 35(6): p. 738-747.

PubDate 1994
Copyright © 2020. Record / license number: Chongqing ICP No. 2000214